JUBILANT PHARMA UK LIMITEDActive

Company number 11952129Private limited companyIncorporated 2019

Key figures

£558,584+10.0%
Net assets 2025/26
+155.5%
Average annual growth 2023/24–2025/26
0200 k400 k600 k2023/242024/252025/26

JUBILANT PHARMA UK LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 m5 m7.5 m2023/242024/252025/26
Filed accounts2023/24–2025/26
2023/242024/252025/26
Profit for the year261,395422,13550,914
Cash at bank and in hand142,839239,015107,944
Total assets6,600,8356,210,2733,273,671
Total liabilities6,515,3005,701,9712,714,725
Net assets / total equity85,535507,670558,584
Average number of employees333

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principal activity of the company is that of wholesale of pharmaceutical goods.

As described in the company's latest filed accounts.

Summary: JUBILANT PHARMA UK LIMITED

Company

JUBILANT PHARMA UK LIMITED is a private limited company registered with Companies House under company number 11952129. It was incorporated on 17 Apr 2019. Its status is active. The registered office is in Lower pemberton kennington (TN25). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts. Profit for the year was £50,914. Net assets were £558,584, up 10% on the previous year. Cash at bank and in hand was £107,944. Total assets were £3,273,671 and total liabilities £2,714,725. The company had an average of 3 employees. Figures are available for 3 financial years (2023/24–2025/26).

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 10 Apr 2027.